196 related articles for article (PubMed ID: 23389741)
21. Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders.
Mikhail FM; Lose EJ; Robin NH; Descartes MD; Rutledge KD; Rutledge SL; Korf BR; Carroll AJ
Am J Med Genet A; 2011 Oct; 155A(10):2386-96. PubMed ID: 22031302
[TBL] [Abstract][Full Text] [Related]
22. [Genetic analysis of a case with MEF2C deletion in association with 5q14.3 microdeletion syndrome].
Zhou T; Su W; Liang D; Xu Y; Luo Y; Tong G
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Aug; 38(8):779-782. PubMed ID: 34365624
[TBL] [Abstract][Full Text] [Related]
23. Partial MEF2C deletion in a Cypriot patient with severe intellectual disability and a jugular fossa malformation: review of the literature.
Tanteles GA; Alexandrou A; Evangelidou P; Gavatha M; Anastasiadou V; Sismani C
Am J Med Genet A; 2015 Mar; 167A(3):664-9. PubMed ID: 25691421
[TBL] [Abstract][Full Text] [Related]
24. Prenatal detection of 5q14.3 duplication including MEF2C and brain phenotype.
Cesaretti C; Spaccini L; Righini A; Parazzini C; Conte G; Crosti F; Redaelli S; Bulfamante G; Avagliano L; Rustico M
Am J Med Genet A; 2016 May; 170A(5):1352-7. PubMed ID: 26864752
[TBL] [Abstract][Full Text] [Related]
25. De novo 5q14.3 translocation 121.5-kb upstream of MEF2C in a patient with severe intellectual disability and early-onset epileptic encephalopathy.
Saitsu H; Igarashi N; Kato M; Okada I; Kosho T; Shimokawa O; Sasaki Y; Nishiyama K; Tsurusaki Y; Doi H; Miyake N; Harada N; Hayasaka K; Matasumoto N
Am J Med Genet A; 2011 Nov; 155A(11):2879-84. PubMed ID: 21990267
[TBL] [Abstract][Full Text] [Related]
26. Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females.
Marsh E; Fulp C; Gomez E; Nasrallah I; Minarcik J; Sudi J; Christian SL; Mancini G; Labosky P; Dobyns W; Brooks-Kayal A; Golden JA
Brain; 2009 Jun; 132(Pt 6):1563-76. PubMed ID: 19439424
[TBL] [Abstract][Full Text] [Related]
27. Autistic-like behaviour in Scn1a+/- mice and rescue by enhanced GABA-mediated neurotransmission.
Han S; Tai C; Westenbroek RE; Yu FH; Cheah CS; Potter GB; Rubenstein JL; Scheuer T; de la Iglesia HO; Catterall WA
Nature; 2012 Sep; 489(7416):385-90. PubMed ID: 22914087
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional and functional consequences of alterations to MEF2C and its topological organization in neuronal models.
Mohajeri K; Yadav R; D'haene E; Boone PM; Erdin S; Gao D; Moyses-Oliveira M; Bhavsar R; Currall BB; O'Keefe K; Burt ND; Lowther C; Lucente D; Salani M; Larson M; Redin C; Dudchenko O; Aiden EL; Menten B; Tai DJC; Gusella JF; Vergult S; Talkowski ME
Am J Hum Genet; 2022 Nov; 109(11):2049-2067. PubMed ID: 36283406
[TBL] [Abstract][Full Text] [Related]
29. De novo microduplication of the FMR1 gene in a patient with developmental delay, epilepsy and hyperactivity.
Vengoechea J; Parikh AS; Zhang S; Tassone F
Eur J Hum Genet; 2012 Nov; 20(11):1197-200. PubMed ID: 22549406
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic expansion of the BPTF-related neurodevelopmental disorder with dysmorphic facies and distal limb anomalies.
Glinton KE; Hurst ACE; Bowling KM; Cristian I; Haynes D; Adstamongkonkul D; Schnappauf O; Beck DB; Brewer C; Parikh AS; Shinde DN; Donaldson A; Brautbar A; Koene S; van Haeringen A; Piton A; Capri Y; Furlan M; Gardella E; Møller RS; van de Beek I; Zuurbier L; Lakeman P; Bayat A; Martinez J; Signer R; Torring PM; Engelund MB; Gripp KW; Amlie-Wolf L; Henderson LB; Midro AT; Tarasów E; Stasiewicz-Jarocka B; Moskal-Jasinska D; Vos P; Boschann F; Stoltenburg C; Puk O; Mero IL; Lossius K; Mignot C; Keren B; Acosta Guio JC; Briceño I; Gomez A; Yang Y; Stankiewicz P
Am J Med Genet A; 2021 May; 185(5):1366-1378. PubMed ID: 33522091
[TBL] [Abstract][Full Text] [Related]
31. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
32. A triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx(GCG)10+7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment.
Price MG; Yoo JW; Burgess DL; Deng F; Hrachovy RA; Frost JD; Noebels JL
J Neurosci; 2009 Jul; 29(27):8752-63. PubMed ID: 19587282
[TBL] [Abstract][Full Text] [Related]
33. ARX polyalanine expansion mutations lead to migration impediment in the rostral cortex coupled with a developmental deficit of calbindin-positive cortical GABAergic interneurons.
Lee K; Ireland K; Bleeze M; Shoubridge C
Neuroscience; 2017 Aug; 357():220-231. PubMed ID: 28627419
[TBL] [Abstract][Full Text] [Related]
34. Jugular pit associated with 5q14.3 deletion incorporating the MEF2C locus: a recurrent clinical finding.
Al-Shehhi M; Betts D; Mc Ardle L; Donoghue V; Reardon W
Clin Dysmorphol; 2016 Jan; 25(1):23-6. PubMed ID: 26426104
[No Abstract] [Full Text] [Related]
35. De novo microdeletion of 5q14.3 excluding MEF2C in a patient with infantile spasms, microcephaly, and agenesis of the corpus callosum.
Shimojima K; Okumura A; Mori H; Abe S; Ikeno M; Shimizu T; Yamamoto T
Am J Med Genet A; 2012 Sep; 158A(9):2272-6. PubMed ID: 22848023
[TBL] [Abstract][Full Text] [Related]
36. Epilepsy and outcome in FOXG1-related disorders.
Seltzer LE; Ma M; Ahmed S; Bertrand M; Dobyns WB; Wheless J; Paciorkowski AR
Epilepsia; 2014 Aug; 55(8):1292-300. PubMed ID: 24836831
[TBL] [Abstract][Full Text] [Related]
37. Genotype-phenotype correlation of congenital anomalies in multiple congenital anomalies hypotonia seizures syndrome (MCAHS1)/PIGN-related epilepsy.
Fleming L; Lemmon M; Beck N; Johnson M; Mu W; Murdock D; Bodurtha J; Hoover-Fong J; Cohn R; Bosemani T; Barañano K; Hamosh A
Am J Med Genet A; 2016 Jan; 170A(1):77-86. PubMed ID: 26394714
[TBL] [Abstract][Full Text] [Related]
38. Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression.
Zweier M; Gregor A; Zweier C; Engels H; Sticht H; Wohlleber E; Bijlsma EK; Holder SE; Zenker M; Rossier E; Grasshoff U; Johnson DS; Robertson L; Firth HV; ; Ekici AB; Reis A; Rauch A
Hum Mutat; 2010 Jun; 31(6):722-33. PubMed ID: 20513142
[TBL] [Abstract][Full Text] [Related]
39. Not all
Sadleir LG; Mountier EI; Gill D; Davis S; Joshi C; DeVile C; Kurian MA; ; Mandelstam S; Wirrell E; Nickels KC; Murali HR; Carvill G; Myers CT; Mefford HC; Scheffer IE
Neurology; 2017 Sep; 89(10):1035-1042. PubMed ID: 28794249
[TBL] [Abstract][Full Text] [Related]
40. The ARX story (epilepsy, mental retardation, autism, and cerebral malformations): one gene leads to many phenotypes.
Sherr EH
Curr Opin Pediatr; 2003 Dec; 15(6):567-71. PubMed ID: 14631200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
